Xing is a PhD student at the Monash Institute of Pharmaceutical Sciences. Her PhD project, Optimising Antimicrobial Dosing for Specific Patient Groups Through Pharmacokinetic and Pharmacodynamic Modelling to Combat Antimicrobial Resistance, focuses on developing PK/PD models and simulation-based strategies to improve antimicrobial therapy. She is passionate about using quantitative pharmacology to optimise dosing and support global efforts to combat antimicrobial resistance.

Viktorija Erdeljić Turk, MD, PhD, is a physician and consultant clinical pharmacologist at the University Hospital Centre Zagreb, Croatia. Her career has developed across hospital medicine, academia, and regulatory science. Her main professional interests include therapeutic optimization, drug safety, rational use of medicines, and antimicrobial stewardship. She teaches medical and pharmacy students in Croatian, English, and German at the Universities of Zagreb, Rijeka, and Osijek, and has mentored many trainees in clinical pharmacology. She is an experienced clinical trialist with extensive involvement in industry- and academia-sponsored studies. She also serves as an external expert to the Croatian Agency for Medicinal Products and Medical Devices and the European Medicines Agency. Her early work with UNHCR, UNICEF, and WHO contributed to her strong commitment to socially responsible and evidence-based medicine.

Dr. Mansur A. Ramalan is a Consultant Physician specializing in Endocrinology, Diabetes, and Clinical Pharmacology. He holds dual fellowships of the National Postgraduate Medical College of Nigeria in Endocrinology/Diabetes and Clinical Pharmacology & Therapeutics. He also holds an MBBS, an MSc in Pharmacology, an MD in Internal Medicine, and currentyl undergoing a PhD in Pharmacology. Dr. Ramalan is a senior lecturer in Clinical Pharmacology and has been actively teaching undergraduate and postgraduate medical students since 2017. His research interests include diabetes, metabolic medicine, clinical pharmacology, vaccinology, and malaria in pregnancy. He has completed a clinical observership at the in Clinical Trials and clinical research at Vanderbilt University, and is expanding his work into vaccine safety and pharmacovigilance. Dr. Ramalan is committed to strengthening clinical research, medical education, and health policy in Nigeria.

Vaishanavi Bamane, Pharm.D., a Research Fellow (Medical) at ACTREC, TMC, Mumbai, specializes in oncology therapeutics and clinical pharmacology. Her research focuses on population pharmacokinetics, exposure–response analysis, and dose optimization of anti-infective and anticancer therapies in special populations plus actively involved in prospective and observational clinical studies and has a strong interest in translational pharmacology, precision dosing, and regulatory science.

Van Dong Nguyen, PharmD, MSc, is a clinical pharmacist with 10 years of experience at the McGill University Health Centre (MUHC), specializing in antimicrobial stewardship and clinical pharmacokinetics. He completed his PharmD and an MSc in Population Health at the Université de Montréal in 2014 and 2023 respectively, as well as a hospital pharmacy residency at the MUHC in 2015. He is currently a PhD candidate at the Université de Montréal Faculty of Pharmacy, where his research focuses on advancing vancomycin PopPK modeling in intermittent high-flux hemodialysis to improve individualized dosing strategies and identifying ideal candidates for MIPD for antimicrobial therapy in the critical care setting. He also teaches as a recurrent guest lecturer and course instructor.